Alteron Therapeutics
1 known investors
Alteron Therapeutics is a pharmaceutical company focused on drug innovation. The available page does not detail its specific therapeutic areas or products.
Investors · 1
Competitors · 3
by search overlapEledon10 shared keywordsEledon Pharmaceuticals is a clinical-stage biotechnology company developing immunology-based therapies, with a focus on protecting transplanted organs from rejection and treating autoimmune and neurodegenerative diseases including ALS. The company's lead candidate is tegoprubart, an anti-CD40L antibody.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Alector8 shared keywordsAlector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration. The company focuses on patients with neurodegenerative conditions and applies genetics, neuroscience, and immunology to advance new treatments.
Companies competing with Alteron Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Alteron Therapeutics do?
- Alteron Therapeutics is a pharmaceutical company focused on drug innovation. The available page does not detail its specific therapeutic areas or products.
- Who are Alteron Therapeutics's investors?
- Alteron Therapeutics's investors include Lair East Labs.